Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

OCGN

+ Watchlist+ Portfolio

Ocugen, Inc.

Regulated industryDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$0.76
52-Week Range
$0.69 – $2.73
Market Cap
$250.82M
P/E (TTM)
—
EPS (TTM)
-0.20
Dividend Yield
0.00%
Advanced Metrics
Price/Book
—
PEG Ratio
—
Return on Equity
—
Return on Assets
-52.09%
Gross Margin
0.00%
Operating Margin
-1444.14%
Profit Margin
0.00%
Current Ratio
0.77
Debt/Equity
—
Total Debt
$88.56M
Free Cash Flow
$-21.49M
Revenue Growth
11.40%
Earnings Growth
—
Enterprise Value
$255.12M

Market Snapshot

About

Ocugen, Inc. is a biotechnology company developing gene therapies and cell therapies to cure blindness and treat eye diseases including inherited retinal diseases.